IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2023

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 219 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Bayesian Capital Management, LP 83,420$587,2770.06%
CARLSON CAPITAL L P 104,474$735,4970.06%
Virtus ETF Advisers LLC 12,542$88,2960.05%
Artisan Partners Limited Partnership 4,426,741$31,164,2570.05%
Polar Asset Management Partners Inc. 396,700$2,792,7680.05%
PICTET ASSET MANAGEMENT SA 5,175,080$36,432,5630.04%
Rafferty Asset Management, LLC 1,052,921$7,412,5640.04%
CORNERCAP INVESTMENT COUNSEL INC 32,164$226,4350.04%
KENNEDY CAPITAL MANAGEMENT LLC 225,909$1,590,3990.04%
ARK Investment Management 775,787$5,461,5420.04%
CIM INVESTMENT MANAGEMENT INC 13,773$96,9620.03%
BANQUE PICTET & CIE SA 534,158$3,760,4720.03%
E Fund Management Co., Ltd. 56,609$3990.03%
TWO SIGMA INVESTMENTS, LP 1,531,053$10,778,6130.03%
ExodusPoint Capital Management, LP 449,900$3,1670.03%
SANDERS MORRIS HARRIS LLC 16,200$115,0200.02%
BALYASNY ASSET MANAGEMENT L.P. 1,539,807$10,840,2410.02%
DARK FOREST CAPITAL MANAGEMENT LP 36,381$256,1220.02%
DUALITY ADVISERS, LP 24,421$171,9240.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 515,035$3,625,8460.02%
External links

This page lists IOVANCE BIOTHERAPEUTICS INC's shareholders in Q2 2023. To view IOVANCE BIOTHERAPEUTICS INC's shareholder history, click here.